RUBIUS THERAPEUTICS INC

CUSIP: 78116T103 Class: COM

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 353,813 Value ($000) $301 Avg Close — Range —
Q1 2022
Shares 56,927 Value ($000) $314 Avg Close — Range —